Rhythm Pharmaceuticals Inc. is a biopharmaceutical company focused on the development and commercialization of therapies for rare genetic disorders. The company’s lead product candidate, setmelanotide, has shown promising results in clinical trials for the treatment of obesity caused by certain genetic mutations. Rhythm Pharmaceuticals aims to improve the lives of patients suffering from these rare disorders through innovative and targeted therapies.
